Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules
NCT: NCT06825078 · RECRUITING
Brief Summary
Lung cancer screening trials using low-dose chest CT scans have shown a significant reduction of cancer related mortality in subjects at high risk of lung cancer. However, high rate of false positives and overdiagnosis have led to invasive methods, which are not without risks. Evaluation of lung nodules using lung MRI with ultra short echo time sequences (UTE) has been found comparable to chest CT scans. Moreover, MRI has the advantage of multiparametric characterization of lesions using different tissue contrasts. Following the recommendation of the French National Authority for Health (HAS) to evaluate new methods of lung cancer screening, this prospective single center pilot study is designed to evaluate the performance of multiparametric lung MRI combined to synthetic CT in the diagnosis of lung cancer in heavily smokers or ex-smokers professionally exposed to carcinogens
Frequently Asked Questions
What is Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules?
Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules is a clinical trial registered under NCT06825078. Current status: RECRUITING.
What is the status of NCT06825078?
The current status of NCT06825078 (Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules) is: RECRUITING.
When did Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules start?
Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules started on 2025-02-12.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.